IMUGENE CHART. TA only, page-686

Talking about big pharma deal.

Thinking out loud here. There are currently quite a few biosims fighting for a share of the market against the original drugs like Herceptin, Tecentriq, etc. If a large company like Pfizer is bothered to produce biosims to fight for a small market share, then surely it would make sense that these large pharmas, once convinced of the efficacy, safety and cost of Her-Vaxx would be all over it. After all, with biosims, they can only hope to get a small piece of the action from the original plus at same time having to contend with other biosims. If they can get Her-Vaxx in their hand which is more effective, safer and cheaper to produce, then they can actually take over the whole market. It would render Herceptin and its biosims toothless.

In view of that, if the final result proves up what the IDMC has seen, then a deal is but a foregone conclusion. After all, Her-Vaxx would be like the one ring to bind them all